Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2004
03/04/2004US20040042970 Inhalable sustained therapeutic formulations
03/04/2004US20040042967 Method of treating a systemic disease
03/04/2004US20040042966 Administering aerosol; pressurized measured dosage
03/04/2004US20040042964 Pharmaceutical composition which reduces or eliminates drug abuse potential
03/04/2004DE4325465B4 Orales pharmazeutisches Präparat für die Schmerztherapie An oral pharmaceutical composition for the treatment of pain
03/04/2004DE20318700U1 Chewing cap for medical and therapeutic purposes has a shape and mechanical properties which allow it to be releasable attached to pencils and/or paint brushes used by young children
03/04/2004DE19758730B4 Electrostatic chuck for manufacturing pharmaceutical products e.g. tablets, inhaler substrate
03/04/2004DE10261126A1 Lagerungsstabile, flüssige Fibrinogen-Formulierung Storage stable liquid fibrinogen formulation
03/04/2004DE10239999A1 Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen Granules or powders for the preparation of coatings and binders for pharmaceutical forms
03/04/2004DE10237056A1 Transdermal therapeutic systems containing buprenorphine, useful in treating pain or urinary incontinence, also containing mu-, kappa- or delta-opioid receptor antagonist to reduce abuse potential
03/04/2004CA2499280A1 Inhalation compositions with high drug ratios
03/04/2004CA2499278A1 Method of preparing dry powder inhalation compositions
03/04/2004CA2496364A1 Composition for the carrying and delivery of bone growth inducing material and methods for producing and applying the composition
03/04/2004CA2496110A1 Use of an aqueous solution of citric acid and a water-soluble sugar like lactitol as granulation liquid in the manufacture of tablets
03/04/2004CA2496106A1 Fast dissolving and taste masked oral dosage form comprising sildenafil
03/04/2004CA2495923A1 Methods for treating fungal infections
03/04/2004CA2495913A1 Non-vesicular cationic lipid formulations
03/04/2004CA2495689A1 Pharmaceutical compositions
03/04/2004CA2494974A1 Il-7 drug substance, composition, preparation and uses
03/04/2004CA2494658A1 Use of bupropion for the manufacture of a medicament for treating restless legs syndrome
03/04/2004CA2493328A1 Use of a papaverine-like vasodilator and pharmaceutical composition
03/04/2004CA2492807A1 Nanoparticles for dna administration to a target organ
03/04/2004CA2491758A1 Blood clot-targeted nanoparticles
03/03/2004EP1393749A1 A pharmaceutical preparation in colloidal form useful in the treatment of skin diseases, comprising hyluronic acid
03/03/2004EP1393741A1 Storage-stable, liquid fibrinogen-formulation
03/03/2004EP1393736A1 Use of ginkgo biloba terpene free flavonoidic extract for oral hygiene, and composition containing such extract
03/03/2004EP1393732A1 Minoxidil-containing liquid composition
03/03/2004EP1393724A2 Novel formulations for the transdermal administration of fluoxetine
03/03/2004EP1393721A1 Dosage form of powder agglomerates
03/03/2004EP1393720A1 Vesicle-encapsulated corticosteroids for treatment of cancer
03/03/2004EP1393719A1 Camptothecin-carboxylate formulations
03/03/2004EP1393718A1 Colloidal drug carrier system
03/03/2004EP1393716A2 Cool feeling composition
03/03/2004EP1392846A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING
03/03/2004EP1392840A2 Method for producing proteins by fermentation of microorganisms from the thermus family, the protein mixture thus obtained and cosmetic compositions containing same
03/03/2004EP1392785A1 System for releasing active substances and active agents
03/03/2004EP1392756A2 Lipid-polymer-conjugates
03/03/2004EP1392755A1 Lipid-polymer-conjugates compositions
03/03/2004EP1392389A2 Microprojection array having a beneficial agent containing coating
03/03/2004EP1392381A1 An aerosol forming device for use in inhalation therapy
03/03/2004EP1392375A2 Composition and use of substances for stabilising amino acids containing sulphur
03/03/2004EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs
03/03/2004EP1392364A2 Liquid polymer composition for prevention and treatment of the oral cavity diseases
03/03/2004EP1392352A1 Use of an antioxidant for treating and/or preventing surface ocular disorders
03/03/2004EP1392350A2 Optimization of the molecular properties and formulation of proteins delivered by inhalation
03/03/2004EP1392337A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
03/03/2004EP1392334A2 Therapeutic methods using herbal compositions
03/03/2004EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
03/03/2004EP1392325A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
03/03/2004EP1392321A1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
03/03/2004EP1392277A2 Pharmaceutical compositions comprising a hmg-coa reductase inhibitor
03/03/2004EP1392274A1 Improved dosage form of n-acetyl cysteine
03/03/2004EP1392272A1 Permeation enhancers
03/03/2004EP1392271A1 Swallow tablet comprising paracetamol
03/03/2004EP1392270A2 Abuse resistant pharmaceutical composition containing capsaicin
03/03/2004EP1392265A2 Inhibitors of abc drug transporters at the blood-brain barrier
03/03/2004EP1392264A1 Delivery of antiemetics through an inhalation route
03/03/2004EP1392263A2 Delivery of aerosols containing small particles through an inhalation route
03/03/2004EP1392262A1 Delivery of drug esters through an inhalation route
03/03/2004EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
03/03/2004EP1392260A2 Delivery of benzodiazepines through an inhalation route
03/03/2004EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route
03/03/2004EP1392258A2 Delivery of alprazolam, estazolam, midazolam or triazolam throughan inhalation route
03/03/2004EP1392257A1 Delivery of antihistamines through an inhalation route
03/03/2004EP1392256A1 Improved transdermal therapeutic system for the treatment of parkinson's disese
03/03/2004EP1392255A1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof
03/03/2004EP1392254A1 Micellar drug delivery systems for hydrophobic drugs
03/03/2004EP1392253A2 Gelatin substitute
03/03/2004EP1392252A2 Pharmaceutical composition containing stool softener such as polaxamer and enteric coated particles of bisacodyl
03/03/2004EP1392251A1 Method of tablet enrobing
03/03/2004EP1392250A2 Controlled release dosage forms using acrylic polymer, and process for making the same
03/03/2004EP1392249A1 Nsaid formulation comprising a granular composition and an extra-granular composition
03/03/2004EP1392248A1 Homogenised product for implants and microparticles
03/03/2004EP1392247A2 Process for preparing granular compositions
03/03/2004EP1392246A1 Compaction process for manufacture of sodium phenytoin dosage form
03/03/2004EP1392245A2 Process for making protein delivery matrix and uses thereof
03/03/2004EP1392244A2 Pharmaceutical compositions
03/03/2004EP1392243A2 Topical composition with a lamellar double-membrane structure, containing a n-acyl-ethanolamine and/or a quaternary ammonium salt and/or an adenosylmethionine
03/03/2004EP1392242A1 Method of forming an aerosol for inhalation delivery
03/03/2004EP1392241A2 System for osmotic delivery of pharmaceutically active agents
03/03/2004EP1392240A1 Formulation comprising melt granules of nsaids and organic acids
03/03/2004EP1392133A2 Functional agent for decomposing nicotine and method of preparing the same
03/03/2004EP1392116A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
03/03/2004EP1392115A1 Controlled release particles
03/03/2004EP1259128A4 Water containing soluble fiber
03/03/2004EP1185253B1 Oral administration form for administering a fixed tramadol and diclofenac combination
03/03/2004EP1175257B1 Spray drying apparatus and methods of use
03/03/2004EP1162953B1 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
03/03/2004EP1159049B1 Responsive gels and methods of use thereof
03/03/2004EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
03/03/2004EP1140012B1 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
03/03/2004EP1135092B1 Cleavable solid dosage forms and method for the production thereof
03/03/2004EP1125575B1 Perfusate preparation for ophthalmic operation
03/03/2004EP1113787B1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
03/03/2004EP1100540B1 Process for the preparation of granular and porous sucralfate dry gel
03/03/2004EP1073426B1 Pharmaceutical cyclosporin formulation with improved biopharmaceutical properties, improved physical quality and greater stability, and method for producing said formulation
03/03/2004EP1041968B1 Osmotic delivery system with membrane plug retention mechanism
03/03/2004EP1037615B1 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
03/03/2004EP1019025B1 Peptide/lipid complex formation by co-lyophilization
03/03/2004EP1015017B1 Implantable system with drug-eluting cells for on-demand local drug delivery